Sign in
Taking peopleNo phase

Non-invasive blood pressure monitoring during coil treatment for brain aneurysms

Compares non-invasive and catheter blood pressure monitoring in aneurysm coiling.

Key facts

Who runs it
Korea University Anam Hospital
Where
South Korea1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
NOn-inVAsive Blood Pressure Monitoring in Intracranial Aneurysm Embolization
Status
Recruiting
People taking part
50 people, planned
Started
1 Jan 2026
Expected to end
31 Aug 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Non-invasive continuous blood pressure monitoring
  • Invasive arterial blood pressure monitoring
Record updated
9 April 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with an unruptured brain aneurysm who are scheduled for planned coil treatment under general anesthesia. It compares blood pressure checks with a finger cuff to checks with a tube in the wrist artery.

Age
19 to 80 years
Sex
All sexes
Disease stage
Unruptured intracranial (brain) aneurysm, with planned coil embolization under general anesthesia. Overall health class ASA I-III.

Main reasons for not taking part

  • A tube in the wrist artery cannot be placed, for example due to vessel disease, skin problems there, a missing radial or ulnar artery, or arm bone or joint problems
  • Problems with blood flow in the arms or legs
  • Severe obesity (BMI ≥ 40 kg/m²)
  • Unstable blood pressure or circulation before surgery, or expected around surgery
  • Unable to understand or follow study instructions, or no informed consent

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Adult patients (≥19 and ≤80 years old) scheduled for elective coil embolization of unruptured intracranial aneurysms under general anesthesia
  • American Society of Anesthesiologists (ASA) physical status classification I-III

Who cannot take part

  • Patients in whom radial arterial catheterization is not feasible (e.g., peripheral vascular disease, skin disorders at the insertion site, absence of radial/ulnar artery, or orthopedic conditions of the upper extremity)
  • Patients with peripheral vascular circulatory disorders
  • Patients who do not provide informed consent
  • Patients unable to understand or follow study instructions due to physical or mental limitations
  • Patients with morbid obesity (BMI ≥ 40 kg/m²) [Eley et al., 2021]
  • Patients who are hemodynamically unstable preoperatively or expected to be unstable during the perioperative period

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 19 and 80 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to evaluate whether non-invasive continuous blood pressure monitoring (NVBP) using the ClearSight system can safely serve as an alternative to radial arterial catheterization for invasive arterial blood pressure monitoring (IABP) in patients undergoing coil embolization for unruptured intracranial aneurysms.

Read full original descriptionShow less

The main questions it aims to answer are:

* Does NVBP monitoring detect intraoperative hypotension and hypertension events with similar reliability compared to IABP? * Does NVBP monitoring reduce the need for invasive arterial catheterization without compromising patient safety or clinical outcomes?

Researchers will compare patients assigned to NVBP monitoring with those receiving conventional IABP monitoring.

Participants will:

* Be randomly assigned to NVBP monitoring or standard IABP monitoring during coil embolization. * Receive continuous monitoring of cerebral oxygenation with near-infrared spectroscopy (rSO₂). * Undergo standard anesthesia induction, maintenance, and postoperative intensive care protocols. * Have their intraoperative hemodynamic events, vasopressor use, and postoperative outcomes recorded up to 30 days after the procedure.

The 2 groups in the trial

  • NVBP groupTreatment being tested

    Participants undergo continuous non-invasive blood pressure (NVBP) monitoring using the ClearSight system (Edwards Lifesciences, Irvine, CA, USA) during coil embolization for intracranial aneurysm. Cerebral oxygen saturation is simultaneously monitored with O₃® Regional Oximetry (Masimo, CA, USA). A femoral arterial catheter placed for endovascular access may serve as a backup for safety, but invasive radial arterial catheterization is not performed.

    Treatment: Non-invasive continuous blood pressure monitoring

  • IABP groupExisting treatment, for comparison

    Participants undergo standard invasive arterial blood pressure (IABP) monitoring via radial arterial catheterization during coil embolization. Cerebral oxygen saturation is also monitored with O₃® Regional Oximetry (Masimo, CA, USA), identical to the NVBP group.

    Treatment: Invasive arterial blood pressure monitoring

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
A Randomized Controlled Trial on Non-Invasive Continuous Blood Pressure Monitoring as an Alternative to Radial Arterial Catheterization in Patients Undergoing Coil Embolization for Intracranial Aneurysms
Plain-language title
Non-invasive blood pressure monitoring during coil treatment for brain aneurysmsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT07246148, who can take part
Record updated
9 April 2026